Paratek Pharmaceuticals
PRTK
#9008
Rank
NZ$0.22 B
Marketcap
NZ$3.87
Share price
0.00%
Change (1 day)
12.92%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -NZ$72.95 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.16 Billion. In 2022 the company made an earning of -NZ$78.83 Million a decrease over its 2021 earnings that were of -NZ$71.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$72.95 Million-7.47%
2022 -NZ$78.83 Million10.5%
2021 -NZ$71.34 Million-46.16%
2020 -NZ$0.14 Billion-31.93%
2019 -NZ$0.2 Billion11.12%
2018 -NZ$0.18 Billion21.19%
2017 -NZ$0.15 Billion-23.22%
2016 -NZ$0.19 Billion54.68%
2015 -NZ$0.13 Billion309.5%
2014 -NZ$29.73 Million-29.88%
2013 -NZ$42.4 Million
2011 -NZ$6.54 Million-59.18%
2010 -NZ$16.02 Million-53.53%
2009 -NZ$34.47 Million-161.93%
2008 NZ$55.65 M-187.43%
2007 -NZ$63.66 Million11.93%
2006 -NZ$56.87 Million31.69%
2005 -NZ$43.19 Million32.4%
2004 -NZ$32.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$35.88 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.91 Billion 1,086.69%๐Ÿ‡บ๐Ÿ‡ธ USA